RecruitingNCT06758960
Analysis of Biological Progression and Regression of HELLP Syndrome in Time
Biological Evolution of HELLP Syndrome
Sponsor
CHU Mohammed VI Marrakech
Enrollment
70 participants
Start Date
Jul 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Prospective observational study about progression and regression of biological parameters of HELLP syndrome
Eligibility
Sex: FEMALE
Plain Language Summary
Simplified for easier understanding
This study is analyzing blood test results over time in pregnant women admitted to intensive care with HELLP syndrome — a serious complication of pregnancy involving abnormal blood clotting, liver damage, and a low platelet count — to better understand how this condition develops and resolves.
**You may be eligible if...**
- You are a pregnant woman admitted to a maternal ICU with HELLP syndrome based on blood test findings
**You may NOT be eligible if...**
- Your blood abnormalities are caused by a different condition, such as a blood vessel disorder (microangiopathy) or leukemia
- You have received plasma exchange therapy
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06758960
Related Trials
MitoQ to Improve Vascular Funciton in Preeclampsia
NCT072292611 location
Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
NCT063336521 location
Exercise Testing After Preeclampsia
NCT067414361 location
Vagal Stimulation Therapy and Preeclampsia
NCT069531154 locations
Molecular Study of the Maternal-fetal Interface in Preeclampsia.
NCT062326685 locations